Aerosol Delivery of Lung Surfactant and Nasal CPAP in the Treatment of Neonatal Respiratory Distress Syndrome
After shifting away from invasive mechanical ventilation and intratracheal instillation of surfactant toward non-invasive ventilation with nasal CPAP and less invasive surfactant administration in order to prevent bronchopulmonary dysplasia in preterm infants with respiratory distress syndrome, full...
Saved in:
Main Authors: | Frans J. Walther (Author), Alan J. Waring (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluation of a Novel Dry Powder Surfactant Aerosol Delivery System for Use in Premature Infants Supported with Bubble CPAP
by: Robert M. DiBlasi, et al.
Published: (2023) -
Aerosolized Surfactant for Preterm Infants with Respiratory Distress Syndrome
by: Mandy Brasher, et al.
Published: (2021) -
CPAP failure in the management of preterm neonates with respiratory distress syndrome where surfactant is scarce. A prospective observational study
by: Yaser Abdallah, et al.
Published: (2023) -
Comparison of the Therapeutic Effects of Bubble CPAP and Ventilator CPAP on Respiratory Distress Syndrome in Premature Neonates
by: Mahmoud Noori Shadkam, et al.
Published: (2017) -
Titrated flow versus fixed flow Bubble Nasal CPAP for respiratory distress in preterm neonates.
by: Srinivas eMurki, et al.
Published: (2015)